Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Geriatric Medicine
•
Dementia
What is your approach to deprescribing cholinesterase inhibitors and/or memantine in advancing stages of dementia?
Related Questions
How do you choose among SSRIs and dosing strategies for the management of behavioral and psychological symptoms of dementia?
How do you select between antipsychotics in the treatment of delirium refractory to nonpharmacological management in hospitalized older adults with dementia?
Would you recommend a GLP-1 agonist as an option to reduce the risk of dementia in patients with a strong family history?
Are there scenarios in which you would advise using benzodiazepines for the treatment of hyperactive delirium?
How do you approach balancing the treatment of urinary incontinence with anticholinergic medications with the use of cholinesterase inhibitors in dementia?
How do you approach individualizing A1c goals in patients with dementia?
When do you consider using aspirin 81 mg PO BID for VTE prophylaxis over other agents in patients with a fracture, considering recent trial data?
How would you recommend cross-titrating from paroxetine to another SSRI with less anticholinergic burden in an older adult?
What is the role of antibiotic suppression for the prevention of frequent UTIs in older adult patients?
How do you recommend counseling patients on the prognosis of advanced cancer as a generalist who is not highly specialized in cancer literature or cancer-directed therapies?
